Close Menu

NEW YORK – Natera reported after the close of the market on Wednesday that its second quarter revenues grew 16 percent year over year, driven by sales of its Panorama noninvasive prenatal and Horizon carrier screening tests.

For the three months ended June 30, Natera had $86.5 million in revenues, up from $74.4 million a year ago and beating the average Wall Street estimate of $73.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.